No definition available.
Asymptomatic human immunodeficiency virus [HIV] infection status
Z21_ASYMP_HUMAN_IMMUNODEFICIENCY_VIRUS_HIV_INFECTION_STATUS
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
215 |
4. Check minimum number of eventsNone |
215 |
5. Include endpointsNone |
215 |
6. Filter based on genotype QC (FinnGen only) |
190 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_COMMUNICAB_DISEA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z2
Similar endpoints
↥List of similar endpoints to
Asymptomatic human immunodeficiency virus [HIV] infection status
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to communicable diseases
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases
- Factors influencing health status and contact with health services
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1034 | 286 | 725 |
| Only index persons | 929 | 274 | 655 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.01 | 0.02 |
| Only index persons | 0.02 | 0.01 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 37.15 | 31.93 | 39.40 |
| Only index persons | 36.71 | 31.33 | 38.96 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 190 | 32 | 158 |
| Unadjusted period prevalence (%) | 0.06 | 0.01 | 0.07 |
| Median age at first event (years) | 39.60 | 38.98 | 39.72 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 215
- Matched controls
- 2150
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
311.3
215
*
WW200
NOMESCO Finland
Immunization
344.3
307.7
171
24
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
4651.2
255.7
196
5
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
53.8
199.3
142
75
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
1011.5
144.7
126
*
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
23.1
112.3
100
78
Z25.1
ICD-10 Finland
Need for immunization against influenza
41.9
101.8
65
22
Z3231
NOMESCO Finland
Registered nurse
11.9
74.5
148
336
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
676.3
55.1
52
*
Z2221
NOMESCO Finland
Medical doctor
7.9
52.5
126
326
A63.0
ICD-10 Finland
Anogenital (venereal) warts
13.0
37.5
39
36
A51.0
ICD-10 Finland
Primary genital syphilis
424.8
37.2
36
*
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
406.3
35.0
34
*
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
+∞
29.9
28
*
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
36.4
26.9
34
11
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
9.1
26.3
35
45
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
25.5
24
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
24.9
137
615
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
23.4
22
*
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
256.2
23.1
23
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.7
18.4
38
78
TAB00
NOMESCO Finland
Lumbar puncture
7.0
18.2
30
49
A51.9
ICD-10 Finland
Early syphilis, unspecified
+∞
18.0
17
*
A54.5
ICD-10 Finland
Gonococcal pharyngitis
+∞
18.0
17
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.9
17.6
35
69
B18.2
ICD-10 Finland
Chronic viral hepatitis C
18.3
17.0
26
16
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
4.9
16.6
41
98
Y25
ICPC
Fear sexually transm disease male
7.9
16.0
23
32
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.9
15.9
26
42
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
7.7
15.6
23
33
Z01.2
ICD-10 Finland
Dental examination
3.0
14.3
123
659
N05CF01
ATC
zopiclone; oral
3.1
13.8
86
384
WX110, ,
SPAT
4.7
12.8
32
77
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
12.8
12.6
22
19
J05AB01
ATC
aciclovir; systemic
3.2
12.1
59
226
ULA02
NOMESCO Finland
Kolposcopy
5.5
11.8
24
48
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
3.0
11.7
69
294
Z3226
NOMESCO Finland
Physiotherapist
3.2
10.6
49
181
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
34.4
10.5
13
*
S02.51
ICD-10 Finland
Fracture of tooth, open
3.7
10.4
36
110
TLC02
NOMESCO Finland
Simple extraction of IUD
24.8
10.4
14
6
ZXE00
NOMESCO Finland
One hour or less
2.6
10.0
92
486
Z3232
NOMESCO Finland
Midwife
5.1
10.0
22
47
D07BA04
ATC
hydrocortisone and antiseptics; topical
4.1
10.0
29
78
ZX114
NOMESCO Finland
Intramuscular
14.3
9.8
16
12
N05CD07
ATC
temazepam; oral
3.9
9.6
30
85
P19
ICPC
Drug abuse
104.4
9.5
10
*
WYA30, ,
SPAT
22.9
9.5
13
6
Z71.8
ICD-10 Finland
Other specified counselling
2.6
9.5
78
390
A53.9
ICD-10 Finland
Syphilis, unspecified
+∞
9.4
9
*
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
+∞
9.4
9
*
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
4.7
8.8
21
48
Z2446
NOMESCO Finland
Social worker
4.4
8.8
23
57
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
11.4
8.4
15
14
K02.9
ICD-10 Finland
Dental caries, unspecified
11.4
8.4
15
14
R4110
NOMESCO Finland
Physiotherapy
2.5
8.4
70
349
N06AB04
ATC
citalopram; systemic
2.7
8.3
53
232
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.5
8.3
65
315
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.8
8.1
49
208
EB1AA, ,
SPAT
3.6
7.8
27
82
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
3.8
7.5
24
69
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
82.8
7.5
8
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
7.4
53
245
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
7.3
37
142
J05AB11
ATC
valaciclovir; oral
2.9
7.3
37
142
TLC00
NOMESCO Finland
Insertion of intrauterine device
7.0
7.3
17
26
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.4
7.3
18
30
N05BB01
ATC
hydroxyzine; systemic
4.3
7.2
19
47
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
31.2
7.2
9
*
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
6.7
7.1
17
27
K02.2
ICD-10 Finland
Caries of cementum
4.6
7.1
17
39
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
8.0
7.0
15
20
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
7.0
79
444
D01AE16
ATC
amorolfine; topical
3.2
7.0
29
99
KMAK, ,
NOMESCO Finland
2.2
7.0
131
899
Z20.2
ICD-10 Finland
Contact with and exposure to infections with a predominantly sexual mode of transmission
14.4
7.0
11
8
N05BA04
ATC
oxazepam; oral
2.4
6.7
59
298
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.7
6.6
38
156
F43.29
ICD-10 Finland
Adaptation disorder UNS
6.6
6.6
16
26
C10AA07
ATC
rosuvastatin; oral
2.2
6.5
80
463
D10AF01
ATC
clindamycin; topical
3.9
6.4
19
52
B37.4
ICD-10 Finland
Candidiasis of other urogenital sites
18.7
6.3
9
5
B20.9
ICD-10 Finland
HIV disease resulting in unspecified infectious or parasitic disease
+∞
6.3
6
*
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
+∞
6.3
6
*
Y71
ICPC
Gonorrhoea male
+∞
6.3
6
*
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
+∞
6.3
6
*
P18
ICPC
Medication abuse
27.6
6.3
8
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.2
6.1
69
385
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
174
11
825.25
307.65
3.0
3.6
34.37
36.40
%
—
45
5
188
13
1144.60
307.65
2.7
2.0
33.78
39.41
%
0.72
188
13
71
62
16.60
72.77
6.4
1.5
—
—
—
0
0
75
74
15.03
71.28
6.2
1.7
—
—
—
0
0
198
656
26.53
70.54
14.9
3.6
34.86
36.17
u/l
0.14
198
624
183
623
14.02
60.32
5.3
5.6
39.60
36.79
g/l
10.93
183
599
195
775
17.30
53.20
3.9
2.7
0.00
0.01
estimate
0.50
17
137
195
778
17.19
52.88
6.6
3.7
0.00
0.00
estimate
-0.00
17
133
195
783
17.02
52.36
3.9
2.7
0.00
0.00
estimate
-0.00
17
122
37
20
22.14
47.59
1.0
1.1
—
—
—
0
0
215
1253
+∞
47.22
12.7
8.0
74.59
76.89
u/l
0.59
215
1195
195
956
12.18
37.12
6.0
5.8
5.97
6.75
mmol/l
11.96
195
906
87
214
6.15
36.18
5.3
1.7
—
—
—
0
0
79
190
5.99
33.38
4.9
1.7
—
—
—
0
0
35
10
41.44
28.45
2.3
2.7
15.43
14.20
%
—
35
10
103
401
4.01
22.38
3.8
2.6
0.06
0.40
e6/l
4.44
80
299
23
5
51.22
19.62
5.7
1.6
—
—
—
0
0
24
9
29.77
18.25
3.9
3.0
—
—
—
0
0
110
516
3.32
16.82
3.9
2.7
—
—
—
0
0
29
53
6.17
15.72
1.0
1.3
183.15
206.65
miu/ml
0.12
13
28
18
5
39.04
14.69
3.2
1.8
—
—
—
0
0
22
14
17.34
14.27
2.0
1.5
—
—
—
0
0
59
225
3.24
12.19
3.3
2.4
3.67
1.23
e6/l
0.39
27
109
202
1531
6.28
11.92
28.2
14.2
13.67
14.41
%
2.06
202
1514
62
250
3.08
11.60
3.2
2.3
0.92
0.99
e6/l
0.07
30
133
67
284
2.97
11.47
1.3
1.3
20.03
21.78
nmol/l
0.50
62
253
215
1940
+∞
8.85
23.1
9.5
34.73
33.70
u/l
0.27
215
1909
35
117
3.38
8.79
2.0
2.4
74.35
70.76
ml/min/173m2
0.26
24
55
10
5
20.86
7.20
1.0
1.0
—
—
—
0
0
17
29
6.27
6.76
1.3
1.5
—
—
—
0
0
17
29
6.27
6.76
1.3
1.5
—
—
—
0
0
17
32
5.67
6.30
3.4
3.1
49.35
57.63
%
1.96
17
32
17
32
5.67
6.30
3.4
2.9
2.94
4.85
e9/l
2.84
17
32
35
146
2.67
5.92
3.2
4.2
195.97
247.46
u/l
2.31
35
139
47
226
2.38
5.92
1.6
2.2
13.55
14.57
umol/l
0.39
47
214
18
51
3.76
5.74
2.4
1.6
—
—
—
0
0
52
273
2.19
5.29
2.2
2.0
2.73
3.10
mg/l
0.45
44
241
28
113
2.70
5.04
1.6
1.4
—
—
—
0
0
41
210
2.18
4.40
1.6
2.2
2.52
2.39
g/l
0.59
41
198
81
529
1.85
4.37
1.8
1.6
95.06
96.63
pmol/l
0.14
52
293
10
16
6.50
4.34
1.1
1.0
—
—
—
0
0
215
2047
+∞
4.16
30.9
16.8
144.29
143.80
g/l
0.20
215
2033
23
94
2.62
4.04
1.9
1.2
—
—
—
0
0
16
54
3.12
3.94
1.5
1.1
—
—
—
0
0
16
55
3.06
3.82
1.5
1.1
—
—
—
0
0
6
5
12.29
3.78
1.7
1.0
—
—
iu/ml
—
0
0
17
62
2.89
3.68
1.2
1.3
—
—
—
0
0
26
133
2.09
2.79
3.0
2.8
—
—
—
0
0
10
30
3.44
2.64
2.7
1.6
—
—
—
0
0
30
167
1.93
2.57
1.8
1.6
—
—
—
0
0
6
11
5.57
2.56
1.2
1.0
—
—
—
0
0
18
83
2.28
2.49
1.3
1.5
2.49
4.03
mg/l
0.46
18
56
14
58
2.51
2.42
1.2
1.7
0.48
0.16
iu/ml
—
7
11
5
8
6.37
2.38
1.0
1.0
33.00
25.00
umol/l
—
5
8
26
142
1.95
2.36
2.2
3.4
0.64
2.00
mmol/l
0.80
19
124
9
28
3.31
2.33
4.0
3.5
19.71
5.66
u/ml
—
9
28
30
174
1.84
2.28
1.8
1.6
—
—
—
0
0
17
80
2.22
2.25
1.5
1.4
—
—
—
0
0
10
37
2.78
2.10
1.2
1.3
—
92.50
—
0
10
52
716
0.64
2.09
2.8
3.1
25.19
21.69
%
0.44
24
235
7
20
3.58
2.07
4.1
3.9
—
—
—
0
0
8
26
3.15
2.03
1.5
1.8
—
—
—
0
0
10
38
2.71
2.03
1.1
2.2
—
—
—
0
0
124
1433
0.68
1.99
4.9
3.2
60.86
53.83
u/l
0.39
116
1384
7
21
3.41
1.98
1.0
1.1
—
—
—
0
0
5
11
4.62
1.95
1.0
1.1
499.80
246.95
iu/ml
—
5
11
6
17
3.60
1.85
1.0
1.1
—
—
—
0
0
12
53
2.34
1.84
3.1
2.5
—
—
—
0
0
6
18
3.40
1.76
1.2
1.2
—
—
—
0
0
15
272
0.52
1.69
1.4
1.8
—
—
—
0
0
87
698
1.41
1.67
4.8
8.9
1.21
1.21
mmol/l
0.05
78
615
11
49
2.31
1.66
1.1
1.1
—
—
—
0
0
5
14
3.63
1.62
1.2
1.4
—
—
—
0
0
6
20
3.06
1.59
1.0
1.2
—
—
—
0
0
7
28
2.55
1.46
3.9
3.8
—
1188.40
—
0
5
9
41
2.25
1.38
1.1
1.3
561.89
447.22
mg/l
—
9
41
19
113
1.75
1.37
2.5
1.8
235.37
223.30
pmol/l
0.26
19
107
60
466
1.40
1.35
3.3
3.9
11.79
8.52
mg/mmol
0.31
38
315
41
297
1.47
1.34
3.1
3.2
187.79
292.81
ng/l
0.27
32
215
38
271
1.49
1.34
2.1
3.5
0.82
0.83
mmol/l
0.10
33
257
34
238
1.51
1.31
1.8
1.8
—
—
—
0
0
57
712
0.73
1.24
2.3
2.6
—
—
—
0
0
5
19
2.67
1.22
1.2
1.2
—
—
—
0
0
0
33
0.00
1.17
0.0
1.6
—
—
—
0
0
45
575
0.73
1.11
2.3
3.0
13.12
37.13
ng/l
2.64
21
352
10
52
1.97
1.08
1.5
1.3
—
—
—
0
0
78
652
1.31
1.07
8.1
10.5
1.06
1.16
inr
1.02
18
190
75
883
0.77
1.04
3.2
3.2
1.70
1.46
ug/l
0.51
68
823
17
107
1.64
1.03
1.2
1.7
—
—
—
0
0
0
31
0.00
0.97
0.0
1.6
—
—
—
0
0
7
37
1.92
0.95
1.0
1.1
—
1.70
—
0
20
10
163
0.59
0.82
6.6
8.4
—
—
—
0
0
51
614
0.78
0.81
5.0
2.6
—
—
—
0
0
6
34
1.79
0.77
1.0
1.1
—
—
—
0
0
45
370
1.27
0.69
2.0
2.3
—
—
—
0
0
8
129
0.61
0.66
5.6
6.2
2.10
39.96
ug/l
—
8
109
5
29
1.74
0.64
1.4
1.4
—
—
—
0
0
5
29
1.74
0.64
3.0
2.5
—
—
—
0
0
5
29
1.74
0.64
1.6
1.4
—
—
—
0
0
5
29
1.74
0.64
1.4
1.4
—
—
—
0
0
45
530
0.81
0.59
2.4
2.3
0.97
0.62
ug/l
0.50
36
265
37
445
0.80
0.58
1.3
2.4
366.55
4794.89
umol/l
1.30
31
407
6
35
1.73
0.58
1.0
1.3
—
—
—
0
0
6
36
1.69
0.57
1.2
1.2
3.40
3.69
mmol/l
—
6
36
141
1330
1.17
0.50
3.5
3.2
—
—
—
0
0
5
31
1.63
0.43
1.4
1.6
—
—
—
0
0
51
449
1.18
0.42
6.3
3.6
2.37
2.35
mmol/l
0.39
44
410
5
32
1.58
0.42
1.0
2.1
22.50
24.09
mmol/l
—
5
32
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
125
1179
1.14
0.41
3.1
3.4
13.72
14.60
pmol/l
4.72
119
1096
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
26
218
1.22
0.36
4.1
2.9
2.44
2.43
mmol/l
0.12
21
189
7
97
0.71
0.31
2.3
3.0
1.25
1.23
mmol/l
—
7
91
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
18.80
—
0
10
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
46.67
—
0
12
22
250
0.87
0.21
1.3
1.2
6.72
4.96
u/ml
—
5
110
0
13
0.00
0.21
0.0
4.3
—
70.92
—
0
13
40
366
1.11
0.21
1.8
1.9
1.13
1.04
mg/l
0.12
33
282
0
14
0.00
0.20
0.0
1.8
—
4.00
—
0
8
0
14
0.00
0.20
0.0
2.4
—
14.57
—
0
14
6
50
1.21
0.20
1.0
3.0
0.71
1.00
nmol/l
—
6
45
13
153
0.84
0.18
10.5
16.4
118.69
125.97
g/l
0.55
13
148
20
176
1.15
0.18
7.8
14.8
0.12
1.04
mmol/l
0.31
13
141
10
83
1.21
0.15
1.3
1.0
—
—
—
0
0
14
124
1.14
0.11
1.2
1.2
—
22.84
—
0
9
39
371
1.06
0.09
5.6
3.1
0.00
0.01
estimate
0.50
17
126
7
65
1.08
0.08
1.0
1.1
—
2.63
—
0
11
7
83
0.84
0.07
1.7
1.3
—
—
—
0
0
33
317
1.05
0.05
1.4
1.4
—
—
—
0
0
21
205
1.03
0.00
8.4
9.9
104.52
103.85
mmol/l
0.32
21
205
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
27.78
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
7.60
—
0
5
0
5
0.00
0.00
0.0
1.4
—
63.40
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.6
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
11.28
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
208.00
—
0
6
9
96
0.93
-0.00
2.0
2.1
452.44
124.84
ng/l
—
9
81
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
230.57
—
0
7
0
8
0.00
-0.00
0.0
4.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
60.52
—
0
6
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Z21_ASYMP_HUMAN_IMMUNODEFICIENCY_VIRUS_HIV_INFECTION_STATUS and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Z21_ASYMP_HUMAN_IMMUNODEFICIENCY_VIRUS_HIV_INFECTION_STATUS | 2.926 [2.33, 3.68] | < 0.001 |
| Birth year | 0.985 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 116 out of 694 males with Z21_ASYMP_HUMAN_IMMUNODEFICIENCY_VIRUS_HIV_INFECTION_STATUS died.
Mortality risk
Mortality risk for people of age
years, who have Z21_ASYMP_HUMAN_IMMUNODEFICIENCY_VIRUS_HIV_INFECTION_STATUS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.587% |
| 5 | No data | 3.198% |
| 10 | No data | 7.823% |
| 15 | No data | 14.841% |
| 20 | No data | 24.18% |
Relationships between endpoints
↥Index endpoint: Z21_ASYMP_HUMAN_IMMUNODEFICIENCY_VIRUS_HIV_INFECTION_STATUS – Asymptomatic human immunodeficiency virus [HIV] infection status
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data